Next Big Biotech Stock To Buy: Hedge Funds’ New Moves

James E. Flynn‘s Deerfield Management is the largest stockholder of Antares Pharma Inc (NASDAQ:ATRS) within our database and holds about 18.39 million shares valued at $38.25 million after a 53% hike in the stake during the second quarter. Steven Boyd‘s Armstice Capital also recently hiked its stake in Antares to 8.06 million shares.

Allscripts Healthcare Solutions Inc (MDRX) has been on Iridian’s equity portfolio since the third quarter of 2012. The $2.51 billion Chicago-based company is engaged in providing clinical, financial, population health management, transaction and managed IT services among other solutions to its clients which span 11 countries. So far this year, Allscripts Healthcare Solutions Inc (MDRX)’s stock price has climbed by more than 2.7% as compared to 10.89% average gains for the software-application industry. In its financial results for the second quarter the company managed to beat both the top and bottom line estimates by delivering an EPS of $0.12 on top of $351.47 million revenues. The gross margins were at the highest level since early 2014, while bookings were up by 6% on a year-to-date basis. Moreover, a total of 180 new clients were added during the trimester coming from a wide spectrum including hospitals, international markets and post-acute providers.

Among the funds that we track Clifton S. Robbins’ Blue Harbour Group is the largest stockholder of Allscripts Healthcare Solutions Inc (MDRX) holding some 14.42 million shares valued at $197.30 million.

Disclosure: None